Glutathione (1500 mg Vial) Dosage Protocol

Dosing & Reconstitution Overview

Glutathione (GSH) is a small tripeptide of glutamate, cysteine and glycine that serves as the principal intracellular antioxidant. The figures below are compiled strictly for laboratory and educational reference — they describe how the compound is handled and measured in published research models, not a recommendation for use in humans or animals.

For a 1500 mg vial, adding 5.0 mL of bacteriostatic water yields a concentration of 300 mg/mL. At that fill, each single unit on a U-100 insulin syringe equals 0.01 mL and carries 3 mg of material, so a 100 mg measurement works out to about 33 units (0.33 mL). Holding the concentration at 300 mg/mL keeps the per-unit arithmetic identical to smaller fills while letting one vial supply many draws.

Standard (Gradual) Titration Schedule

The gradual schedule steps the daily research amount upward over several weeks, a pattern used in the literature to keep gastrointestinal tolerability comfortable before settling at a maintenance level.

Reconstitution Steps

1. Let the sealed lyophilized vial and the bacteriostatic water reach room temperature, then wipe both stoppers with an alcohol swab.
2. Draw 5.0 mL of bacteriostatic water and inject it slowly down the inside wall of the vial — direct the stream against the glass rather than onto the powder to avoid foaming.
3. Swirl or roll gently until fully dissolved. Do not shake; aggressive agitation can shear the peptide.
4. The solution should be clear. Label the vial with the concentration (300 mg/mL) and the reconstitution date.
5. Store upright under refrigeration, protected from light, and draw subsequent volumes with a fresh sterile syringe each time.

Maintenance (Reduced-Frequency) Schedule

Where the gradual schedule front-loads daily handling, some research models shift to a reduced-frequency pattern once the working level is reached, sampling once or twice weekly rather than daily.

Supplies Needed

• Glutathione vials (1500 mg): ~2 vials for a 4-week daily run averaging 100–150 mg; ~3 vials for an 8-week run averaging 150–200 mg.
• Insulin syringes (U-100, 1 mL): ~28 for a 4-week daily schedule; ~56 for 8 weeks (one fresh syringe per draw).
• Bacteriostatic water (10 mL): one 10 mL bottle reconstitutes two 1500 mg vials; a second bottle covers a 3-vial run.
• Alcohol swabs: a single 100-count box covers a 4-week schedule; two boxes for an 8-week schedule.

Protocol Overview

• Research goal: model intracellular antioxidant capacity, redox buffering and Phase II detoxification support.
• Schedule: once-daily or every-other-day subcutaneous administration in the published model, with reduced-frequency maintenance.
• Dose band: 100–200 mg daily.
• Fill: 1500 mg lyophilized, reconstituted to 300 mg/mL with 5 mL diluent.
• Storage: −20 °C dry; 2–8 °C once reconstituted.

Dosing Protocol Notes

• Begin at the lowest 100 mg step and hold each level for one to two weeks before escalating.
• Keep administration on a fixed daily or alternating-day cadence for steady exposure modelling.
• Slower titration is favoured where high-dose gastrointestinal effects are a concern.
• The 200 mg level represents the upper end of the commonly cited research band for this route.

Storage Instructions

Keep sealed lyophilized vials at −20 °C, in dry, dark conditions with minimal moisture exposure, where stability extends for many months. Once reconstituted, refrigerate at 2–8 °C and use within about two to three weeks for best potency. Allow refrigerated solution to reach room temperature before drawing, avoid freeze-thaw cycles, and aliquot if a vial will be sampled many times. Glutathione in solution is sensitive to oxidation, so keep it shielded from light and air.

Important Handling Notes

• Use a sterile syringe for every draw and never re-enter the vial with a used needle.
• Minimise air contact when drawing, since the reduced thiol oxidises readily.
• Rotate handling technique to keep the stopper intact across many draws.
• Document each draw — date, volume, remaining material — for reproducibility.

How Glutathione Works

Glutathione is the most abundant intracellular antioxidant, present in nearly every cell at concentrations on the order of 1–10 mM. Its reduced form (GSH) donates electrons from a cysteine thiol group to neutralise reactive oxygen species, and is regenerated from its oxidised disulfide form (GSSG) by the enzyme glutathione reductase. Beyond direct radical scavenging, it acts as a cofactor for the glutathione peroxidase and glutathione-S-transferase enzyme families, supports Phase II detoxification, and assists the conjugation and clearance of xenobiotics and heavy metals. Maintaining a high GSH:GSSG ratio is a central marker of cellular redox balance, with downstream relevance to mitochondrial protection, hepatic function and immune-cell activity.

Reported Benefits & Side Effects

Benefits reported in the literature

• Reduction of oxidative-stress markers and maintenance of cellular redox equilibrium.
• Support for liver function and hepatic detoxification pathways.
• Immune-modulating signals, including effects on natural-killer-cell and T-cell activity.
• Effects on skin parameters — melanin index and brightness — observed with sustained use in clinical work.

Side effects reported

• Generally well tolerated across studied routes.
• Occasional mild injection-site reactions such as redness or itching with subcutaneous administration.
• Rare gastrointestinal discomfort at higher doses, which gradual titration is used to limit.

Supporting Lifestyle Factors (Research Context)

• Sulfur-rich foods such as cruciferous vegetables, garlic and onions, which supply substrate for endogenous GSH synthesis.
• Limited alcohol exposure, since alcohol depletes hepatic glutathione stores.
• Reduced contact with environmental toxins and other oxidative stressors.
• Adequate sleep and stress management to support antioxidant recycling.
• Complementary nutrients such as vitamin C and selenium that aid glutathione regeneration.

Injection Technique (Reference Only)

• Clean the vial stopper and the site with alcohol swabs and let them dry.
• Pinch a skinfold and insert subcutaneously at a 45–90° angle depending on needle length; aspiration is not required for subcutaneous work.
• Inject slowly and steadily, then wait a few seconds before withdrawing the needle.
• Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy, and dispose of sharps in an approved container.

References

Related Protocols